Beta Bionics (BBNX) Equity Ratio (2023 - 2025)
Beta Bionics' Equity Ratio history spans 3 years, with the latest figure at 0.87 for Q4 2025.
- For Q4 2025, Equity Ratio rose 153.36% year-over-year to 0.87; the TTM value through Dec 2025 reached 0.87, up 153.36%, while the annual FY2025 figure was 0.87, 153.36% up from the prior year.
- Equity Ratio for Q4 2025 was 0.87 at Beta Bionics, down from 0.89 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.93 in Q1 2025 and bottomed at 1.85 in Q4 2023.
- The 3-year median for Equity Ratio is 0.88 (2025), against an average of 0.02.
- The largest annual shift saw Equity Ratio grew 11.17% in 2024 before it surged 153.36% in 2025.
- A 3-year view of Equity Ratio shows it stood at 1.85 in 2023, then grew by 11.17% to 1.64 in 2024, then soared by 153.36% to 0.87 in 2025.
- Per Business Quant, the three most recent readings for BBNX's Equity Ratio are 0.87 (Q4 2025), 0.89 (Q3 2025), and 0.91 (Q2 2025).